TASAKA Taizo | Department of Laboratory Medicine, Kawasaki Medical School
スポンサーリンク
概要
Department of Laboratory Medicine, Kawasaki Medical School | 論文
- Lenalidomide is active in Japanese patients with symptomatic anemia in low- or intermediate-1 risk myelodysplastic syndromes with a deletion 5q abnormality
- A Prospective Study of Cyclosporine A Treatment of Patients with Low-Risk Myelodysplastic Syndrome : Presence of CD55^-CD59^- Blood Cells Predicts Platelet Response
- Effects of the Tyrosine Kinase Inhibitor Imatinib Mesylate on a Bcr-Abl-Positive Cell Line : Suppression of Autonomous Cell Growth but No Effect on Decreased Adhesive Property and Morphological Changes
- Diagnostic and biological significance of sideroblastic erythropoiesis in the myelodysplastic syndromes
- Hematological Diseases and Apoptosis